Injectable Hydrogel as a Unique Platform for Antitumor Therapy Targeting Immunosuppressive Tumor Microenvironment

Yushuai Liu1, Yuanyuan Geng2, Beilei Yue2

  • 1Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Frontiers in Immunology
|February 3, 2022
PubMed
Summary

Injectable hydrogels can overcome challenges in cancer immunotherapy by targeting the immunosuppressive tumor microenvironment. This approach enhances immune response against tumors while minimizing side effects.

Related Concept Videos